Mersana Therapeutics
MRSN
MRSN
151 hedge funds and large institutions have $1.83B invested in Mersana Therapeutics in 2020 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% more funds holding
Funds holding: 135 → 151 (+16)
0.01% more ownership
Funds ownership: 4.02% → 4.03% (+0.01%)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
151
Holding in Top 10
6
Calls
$12.1M
Puts
$5.27M
Top Buyers
| 1 | +$51.3M | |
| 2 | +$40.9M | |
| 3 | +$39.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.9M |
| 5 |
BlackRock
New York
|
+$19.6M |
Top Sellers
| 1 | -$111M | |
| 2 | -$55M | |
| 3 | -$17M | |
| 4 |
O
OrbiMed
New York
|
-$14.8M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$14.1M |